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General Information.  Commercial reagents were purified prior to use following the
guidelines of Perrin and Armarego.1 Organic solutions were concentrated under reduced pressure
on a Büchi rotary evaporator.  Chloroform was distilled from calcium hydride prior to use.
Chromatographic purification of products was accomplished using forced-flow chromatography
on ICN 60 32-64 mesh silica gel 63 according to the method of Still.2 Thin-layer
chromatography (TLC) was performed on EM Reagents 0.25 mm silica gel 60-F plates.
Visualization of the developed chromatogram was performed by fluorescence quenching or
anisaldehyde stain.
1H and 13C NMR spectra were recorded on Varian Mercury 300 (300 MHz and 75 MHz
respectively) as noted, and are internally referenced to residual protio solvent signals.  Data for
1H are reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t =
triplet, q = quartet, m = multiplet), integration, coupling constant (Hz) and assignment.  Data for
13C NMR are reported in terms of chemical shift.  IR spectra were recorded on a Perkin Elmer
Paragon 1000 spectrometer and are reported in terms of frequency of absorption (cm-1).  Mass
spectra were obtained from the California Institute of Technology Mass Spectral facility.  High
performance liquid chromatography (HPLC) was performed on Hewlett-Packard 1100 Series
chromatographs using Chiralcel AD column (1.6 x 25 cm) and AD guard (1.6 x 5 cm), Chiralcel
OD−H (1.6 x 25 cm) and OD guard (1.6 x 5 cm), or Chiralcel AS (1.6 x 25 cm) and AS guard
(1.6 x 5 cm) as noted.
General Procedure: To a 2-dram vial equipped with a magnetic stir bar and charged
with L-proline was added chloroform (500 µL) and the suspension cooled to 4 °C.  The
suspension was cooled for 10 minutes before nitrosobenzene (107.1 mg, 1 mmol) was added in
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one portion upon at which time the solution becomes green.  To this green heterogeneous
solution was then added the appropriate aldehyde (3 mmol) in one portion. The resulting solution
was then stirred at 4 °C until the reaction was determined to be complete by TLC and the
disappearance of green color in solution, resulting in a final yellow homogeneous solution.  The
reaction mixture was then transferred to an ethanol suspension of NaBH4 at 0 °C.  After 20
minutes, the reaction was treated with saturated aqueous NaHCO3, extracted with
dichloromethane (3 x 30 mL), dried over Na2SO4, filtered, and concentrated in vacuo.  The
resulting residue was then purified by silica gel chromatography (solvents noted) and fractions
concentrated in vacuo to provide the title compounds.  The enantioselectivity was determined by
chiral HPLC analysis.
5-(Triisopropyl-silanyloxy)-pentanal.      To a round bottom flask equipped with a magnetic
stirring bar was added 5-hydroxypentanal (4.76 mL, 49 mmol), triisopropylsilylchloride (12.6,
58.7 mmol), imidazole (6.67 g, 98 mmol) and CH2Cl2. After 4 h the reaction was treated with
saturated aqueous NH4Cl, extracted with CH2Cl2 (100 mL, 3x), and dried over sodium sulfate to
provide the title compound as a clear oil (1.56 g, 12% yield) after silica gel chromatography (3%
EtOAc/ hexanes).  IR (film) 2943, 2892, 2867, 2716, 1728, 1463, 1389, 1389, 1248, 1106, 1071,
1014, 995.9, 919.3, 882.5, 792.6, 724.7, 680.1, 658.3  cm-1; 1H NMR (300 MHz, CDCl3) δ 9.76
(t, J = 1.9 Hz, 1H, CHO), 3.70 (t, J = 6.1 Hz, 2H, CH2O), 2.46 (dt, J = 1.9, 7.2 Hz, 2H,
CH2CHO), 1.80- 1.50 (m, 4H, CH2CH2CH2CH2), 1.04 (d, J = 3.5 Hz, 18H, 6(CH3)), 1.12- 0.98
(m, 3H, 3(CHCH3)); 13C NMR (75 MHz, CDCl3) δ 202.4, 62.7, 43.5, 32.2, 18.6, 17.9, 11.9;
HRMS (CI) exact mass calcd for (C14H30O2Si) requires m/z 258.2015, found m/z 258.2023.
3-(1-Methyl-1H-indol-3-yl)-propionaldehyde. An amber 2-dram vial equipped with
a magnetic stir bar and containing (2S , 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-
one•trifluoroacetic acid (1 g, 2.8 mmol) was charged with CH2Cl2 (100 mL), then cooled to –50
°C.  The solution is stirred for 5 min before acrolein (12.4 mL, 188 mmol) was added.  After
stirring for an additional 10 minutes, N-methylindole (8 mL, 62 mmol) was added in one portion.
The resulting suspension was stirred at constant temperature until complete consumption of the
N-methylindole as determined by TLC analysis (8 hours).  The reaction mixture was then
transferred cold through a silica gel plug and the filtrates were concentrated in vacuo. The
J. Am. Chem. Soc. Supporting Information S 3
resulting residue was purified by silica gel chromatography (10% EtOAc/ hexanes) to afford the
title compound as a yellow oil (3.5 g, 30% yield).  IR (film) 3041, 2915, 2836, 2713, 1716, 1558,
1540, 1472, 1458, 1370, 1319, 1242, 1150, 1124, 1062, 1006 cm-1; 1H NMR (300 MHz, CDCl3)
δ 9.76 (t, J = 1.6 Hz, 1H, CHO), 7.70- 7.62 (m, 1H, Ar), 7.40- 7.18 (m, 3H, Ar), 6.91 (s, 1H,
CHN), 3.79 (s, 3H, CH3), 3.18 (t, J = 7.2 Hz, 2H, CH2Ar), 2.89 (dt, J = 1.0, 7.2 Hz, 2H,
CH2CHO); 13C NMR (75 MHz, CDCl3) δ 202.1, 136.7, 127.1, 126.0, 121.3, 118.4, 112.6, 109.0,
43.7, 32.0, 17.3; HRMS (CI) exact mass calcd for (C12H13NO) requires m/z 187.0997, found m/z
187.0991.
(R)-2-(N-Phenyl-aminooxy)-propan-1-ol (table 3, entry 1).      Prepared according to
the general procedure from propionaldehyde (216 µL, 3.00 mmol) for 2 h to provide the title
compound as a yellow oil (147.2 mg, 88% yield, 97% ee) after silica gel chromatography (20%
EtOAc/ hexanes).  IR (film) 3380, 3275, 2933, 1601, 1493, 1240, 1153, 1045, 898.5, 766.5,
692.5 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.30- 7.22 (m, 2H, ArH), 7.00- 6.92 (m, 3H, ArH),
4.13- 4.20 (m, 1H, CH), 3.76 (dd, 1H, J = 3.3, 12.1 Hz, CH2), 3.68 (dd, 1H, J = 6.6, 12.1 Hz,
CH2), 1.23 (d, J = 6.6 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) δ 148.4, 128.7, 121.8,
114.3, 79.9, 65.8, 15.4; HRMS (CI) exact mass calcd for (C9H13NO2) requires m/z 167.0946,
found m/z 167.0952.  [α]D = + 1.13 (c = 1.0, CHCl3).  The enantiomeric ratio was determined by
HPLC using a Chiracel AD and AD guard column (10% ethanol / hexanes, 1 mL/min); (S)
isomer tr = 34.4 min and (R) isomer tr = 40.0 min.
(R)-2-(N-Phenyl-aminooxy)-hexan-1-ol (table 3, entry 2).      Prepared according to the general
procedure from hexanal (240 µL, 2.00 mmol) for 2 h to provide the title compound as a yellow
oil (165.2 mg, 79% yield, 98% ee) after silica gel chromatography (20% EtOAc/ hexanes).  IR
(film) 3388, 3274, 3052, 1602, 1494, 1467, 1379, 1345, 1305, 1242, 1057, 1027, 898.8 cm-1; 1H
NMR (300 MHz, CDCl3) δ 7.27 (t, J = 7.7 Hz, 2H, ArH), 7.10- 6.93 (m, 3H, ArH), 3.96- 3.68
(m, 1H, HOCH2CH), 3.05 (s, 1H, OH), 1.76- 1.22 (m, 6H, CH2CH2CH2), 0.92 (t, 3H, CH3); 13C
NMR (75 MHz, CDCl3) δ 148.7, 129.2, 122.5, 115.0, 84.3, 65.4, 30.0, 28.3, 23.2, 14.4; HRMS
(CI) exact mass calcd for (C12H19NO2) requires m/z 210.1494, found m/z 210.1501.  [α]D = + 19.9
(c = 1.0, CHCl3).  The enantiomeric ratio was determined by HPLC using a Chiracel AD and AD
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guard column (5% ethanol / hexanes, 1 mL/min); (S) isomer tr = 25.6 min and (R) isomer tr =
28.7 min.
(R)-3-Methyl-2-(N-phenyl-aminooxy)-butan-1-ol (table 3, entry 3).      Prepared according to
the general procedure from isovaleraldehyde (322 µL, 3.00 mmol) for 2 h to provide the title
compound as a yellow oil (166.0 mg, 85% yield, 99% ee) after silica gel chromatography (20%
EtOAc/ hexanes).  IR (film) 3380, 3260, 3046, 2961, 2873, 1602, 1494, 1469, 1390, 1363, 1234,
1051, 1026, 975.0, 898.7, 764.3, 737.7, 692.2 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.34- 7.20 (m,
3H, ArH, NH), 7.03- 6.94 (m, 3H, ArH), 3.92- 3.76 (m, 2H, CH2), 3.71 (ddd, J = 2.8, 6.0, 6.0 Hz,
1H, CHO), 3.39 (s, 1H, OH), 2.03 (m, 1H, CHMe2), 1.06 (d, J = 6.6 Hz, 3H, CHCH3), 1.00 (d, J
= 7.1 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) δ 148.2, 128.7, 122.1, 114.7, 88.4, 63.1,
28.6, 18.8, 18.6; HRMS (CI) exact mass calcd for (C11H17NO2) requires m/z 195.1259, found m/z
195.1261.  [α]D = + 39.1 (c = 1.0, CHCl3).  The enantiomeric ratio was determined by HPLC
using a Chiracel AD and AD guard column (5% ethanol / hexanes, 1 mL/min); (S) isomer tr =
19.5 min and (R) isomer tr = 22.1 min.
(R)-2-(N-Phenyl-aminooxy)-pent-4-en-1-ol (table 3, entry 4).      Prepared according to the
general procedure from pent-4-enal (296 µL, 3.00 mmol) for 2 h to provide the title compound as
a yellow oil (155.3 mg, 80% yield, 99% ee) after silica gel chromatography (20% EtOAc/
hexanes).  IR (film) 3383, 3279, 3072, 2916, 1643, 1602, 1493, 1426, 1415, 1348, 1244, 1026,
994.8, 917.0, 740.6, 693.9 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.30- 7.15 (m, 2H, ArH), 7.05 (s,
1H, NH), 7.00- 6.96 (m, 3H, ArH), 5.95- 5.81 (m, 1H, CH=CH2), 5.19- 5.10 (m, 2H, CH=CH2),
4.03 (dddd, J = 2.7, 6.6, 6.6, 6.6 Hz, 1H, CH–ON), 3.89- 3.84 (m, 1H, CH2OH), 3.77 (dd, J =
6.0, 12.0 Hz, 1H, CH2OH), 2.56- 2.31 (m, 2H, CH2CH=CH2), 1.80 (s, 1H, OH); 13C NMR (75
MHz, CDCl3) δ 148.2, 133.9, 128.9, 122.3, 117.6, 114.7, 83.3, 64.5, 34.7; HRMS (CI) exact
mass calcd for (C11H15NO2) requires m/z 194.1181, found m/z 194.1173.  [α]D = + 8.0 (c = 0.83,
CHCl3).  The enantiomeric ratio was determined by HPLC using a Chiracel AD and AD guard
column (5% ethanol / hexanes, 1 mL/min); (S) isomer tr = 30.6 min and (R) isomer tr = 36.4 min.
(R)-3-Phenyl-2-(N-phenyl-aminooxy)-propan-1-ol (table 3, entry 5).      Prepared according to
the general procedure from hydrocinnamaldehyde (260 µL, 2.00 mmol) for 4 h to provide the
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title compound as a yellow oil (231.0 mg, 95% yield, 97% ee) after silica gel chromatography
(20% EtOAc/ hexanes).  IR (film) 3385, 3278, 3055, 3028, 2937, 2880, 1601, 1494, 1455, 1346,
1307, 1239, 1082, 1069, 1030, 898.2 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.44- 7.20 (m, 7H,
ArH), 7.01 (t, J = 7.7 Hz, 1H, ArH), 6.86 (d, J = 7.7 Hz, 1H, ArH), 4.16 (dddd, J = 2.2, 6.6, 6.6,
6.6 Hz, 1H, CH), 3.87 (ddd, J = 2.7, 6.6, 12.1 Hz, 1H, CH2OH), 3.79- 3.70 (m, 1H, CH2OH),
3.06 (dd, J = 6.6, 13.7 Hz, 1H, CH2Ph), 3.06 (dd, J = 7.1, 13.7 Hz, 1H, CH2Ph), 2.33 (s, 1H,
OH); 13C NMR (75 MHz, CDCl3) δ 148.7, 138.3, 129.8, 129.2, 128.7, 126.7, 122.4, 114.8, 85.4,
64.1, 36.9; HRMS (CI) exact mass calcd for (C15H17NO2) requires m/z 244.1338, found m/z
244.1344.  [α]D = + 43.1 (c = 1.0, CHCl3).  The enantiomeric ratio was determined by HPLC
using a Chiracel AD and AD guard column (5% ethanol / hexanes, 1 mL/min); (S) isomer tr =
26.8 min and (R) isomer tr = 28.5 min.
(R)-2-Phenyl-2-(N-phenyl-aminooxy)-ethanol (table 3, entry 6).      Prepared according to the
general procedure from phenylacetaldehyde (351 µL, 3.00 mmol) for 2 h to provide the title
compound as a yellow oil (137.4 mg, 60% yield, 99% ee) after silica gel chromatography (20%
EtOAc/ hexanes).  IR (film) 3389, 3277, 3032, 2918 1601, 1494, 1453, 1414, 1350, 1309, 1232,
1027, 896.7, 759.0, 696.4 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.43- 7.24 (m, 7H, ArH), 7.03-
6.95 (m, 4H, NH, ArH), 5.02 (dd, J = 3.3, 8.2 Hz, 1H, CH), 4.04- 3.92 (m, 1H, CH2), 3.88- 3.77
(m, 1H, CH2), 2.66 (dd, J = 4.4, 7.7 Hz, 1H, OH); 13C NMR (75 MHz, CDCl3) δ 148.2, 138.0,
129.3, 128.9, 128.7, 127.3, 122.8, 115.3, 86.8, 66.7; HRMS (CI) exact mass calcd for
(C14H15NO2) requires m/z 229.1103, found m/z 229.1110.  [α]D = - 140.7 (c = 1.0, CHCl3).  The
enantiomeric ratio was determined by HPLC using a Chiracel AD and AD guard column (10%
ethanol / hexanes, 1 mL/min); (S) isomer tr = 26.5 min and (R) isomer tr = 35.0 min.
(R)- 2-(N-Phenyl-aminooxy)-5-(triisopropyl-silanyloxy)-pentan-1-ol (table 3, entry 7).
Prepared according to the general procedure from 5-(triisopropyl-silanyloxy)-pentanal (776 mg,
3.00 mmol) for 2 h to provide the title compound as a yellow oil (267.2 mg, 76% yield, 98% ee)
after silica gel chromatography (20% EtOAc/ hexanes).  IR (film) 3367, 3261, 2942, 2966 1602,
1494, 1463, 1376, 1243, 1103, 1061, 882.3, 725.2, 689.5 cm-1; 1H NMR (300 MHz, CDCl3) δ
7.34- 7.23 (m, 2H, ArH), 7.08 (s, 1H, NH), 7.03- 6.95 (m, 1H, ArH), 4.00 (dddd, J = 2.6, 6.2,
6.2, 6.2 Hz, 1H, CH), 3.91- 3.66 (m, 4H, CH2OH, CH2OSi), 2.68 (s, 1H, OH); 1.85- 1.58 (m, 4H,
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CH2CH2), 1.14- 1.02 (m, 21H, (CH(CH3)2)3); 13C NMR (75 MHz, CDCl3) δ 148.6, 129.3, 122.7,
115.1, 84.1, 65.6, 63.4, 29.3, 26.5, 18.3, 12.2; HRMS (CI) exact mass calcd for (C20H37NO3Si)
requires m/z 367.2543, found m/z 367.2549.  [α]D = + 17.1 (c = 1.0, CHCl3).  The enantiomeric
ratio was determined by HPLC using a Chiracel AS and AS guard column (0.2% ethanol /
hexanes, 1 mL/min); (S) isomer tr = 74.0 min and (R) isomer tr = 88.6 min.
(R)-3-(1-Methyl-1H-indol-3-yl)-2-(N-phenyl-aminooxy)-propan-1-ol (table 3, entry 8).
Prepared according to the general procedure from 3-(1-methyl-1H-indol-3-yl)-propionaldehyde
(561.7 mg, 3.00 mmol) for 4 h to provide the title compound (83% NMR yield, 98% ee).  IR
(film) 3401, 3266, 3049, 2928 1601, 1546, 1494, 1473, 1424, 1376, 1328, 1249, 1155, 1127,
1065, 1028, 1012, 898.6, 740.1, 693.9, 565.8 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.70 (dd, J =
0.8, 8.0, Hz, 1H, ArH), 7.40- 6.96 (m, 9H, Ar), 4.36- 4.27 (m, 1H, CHON), 3.93 (dd, J = 2.7,
12.0 Hz, 1H, CH2OH), 3.83 (dd, J = 5.8, 12.0 Hz, 1H, CH2OH), 3.79 (s, 3H, CH3), 3.28 (dd, J =
5.8, 14.6 Hz, 1H, CH2Ar), 3.07 (dd, J = 8.0, 14.6 Hz, 1H, CH2Ar); 13C NMR (75 MHz, CDCl3) δ
148.5, 136.9, 128.9, 127.9, 127.5, 122.3, 121.6, 118.9, 118.9, 114.7, 110.1, 109.2, 84.3, 64.3,
32.5, 25.6; HRMS (CI) exact mass calcd for (C18H20N2O2) requires m/z 367.2543, found m/z
367.2549.  [α]D = + 25.7 (c = 1.0, CHCl3).  The enantiomeric ratio was determined by HPLC
using a Chiracel AD and AD guard column (15% ethanol / hexanes, 1 mL/min); (S) isomer tr =
25.6 min and (R) isomer tr = 32.5 min.
(R)-O-(2-Dibenzylamino-1-methyl-ethyl)-N-phenyl-hydroxylamine (equation 3).  To a 2-
dram vial equipped with a magnetic stir bar and charged with L-proline was added chloroform
(500 µL) and the suspension cooled to 4 °C.  After 10 minutes, nitrosobenzene (107.1 mg, 1
mmol) was added in one portion at which time the solution became green.  To the green
heterogeneous solution was added propionaldehyde (216 µL, 3 mmol) in one portion. The
resulting solution was stirred at 4 °C until the reaction was determined to be complete by TLC
and the disappearance of the green color in solution, resulting in a final yellow homogeneous
solution (2 h).  The reaction mixture was then concentrated and transferred, using CH2Cl2 (2
mL), to a vial at 0 °C containing dibenzylamine (385 µL, 2.0 mmol) and sodium
triacetoxyborohydride (424 mg, 2.0 mmol) in CH2Cl2 (6 mL).  After stirring at 0 °C for 6 h the
was resulting solution with treated with saturated aqueous NaHCO3, extracted with CH2Cl2 (3 x
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30 mL), dried over Na2SO4, filtered, and concentrated in vacuo.  The resulting residue was then
purified by silica gel chromatography (10% EtOAc/ hexanes) and the fractions concentrated in
vacuo to provide the title compound as a yellow oil (267.2 mg, 71% yield, 96% ee).  IR (film)
3383, 3048, 3027, 2971, 2930, 2799, 1602, 1494, 1452, 1372, 1334, 1307, 1243, 1121, 1077,
1059, 1028, 977.3, 892.5, 864.3, 737.3, 697.5, 484.3 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.58-
6.97 (m, 16H, ArH, NH), 4.32- 4.18 (m, 1H, CH), 3.85 (d, J = 13.4 Hz, 2H, (CH2Ar)2), 3.72 (d, J
= 13.4 Hz, 2H, (CH2Ar)2), 2.94 (dd, J = 7.0, 13.5 Hz, 1H, CH2CH), 2.61 (dd, J = 4.7, 13.5 Hz,
1H, CH2CH), 1.35 (s, J = 6.2 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 149.5, 139.8, 129.4,
129.2, 129.1, 128.8, 128.7, 128.5, 127.4, 121.7, 114.4, 59.6, 58.6, 18.1; HRMS (CI) exact mass
calcd for (C23H26N2O) requires m/z 347.2123, found m/z 347.2126.  [α]D = + 29.1 (c = 1.0,
CHCl3).  The enantiomeric ratio was determined by HPLC using a Chiracel AD and AD guard
column (5.0% isopropanol / hexanes, 1 mL/min); (S) isomer tr = 14.6 min and (R) isomer tr =
25.0 min.
Stereochemical Analysis
Procedure for CuSO4 N–O bond cleavage: To a 2-dram vial equipped with a magnetic
stir bar and charged with the appropriate oxy–aniline adduct was added methanol (3 mL) and the
solution cooled to 4 °C.  After 10 minutes, copper sulfate (30 mmol %) was added in one
portion. The resulting solution was then stirred at 4 °C until the reaction was determined to be
complete by TLC analysis.  The reaction was then treated with saturated aqueous sodium
chloride, extracted with EtOAc (3 x 30 mL), dried over Na2SO4, filtered, and concentrated in
vacuo.  The resulting residue was purified by silica gel chromatography (50% EtOAc / hexanes)
and fractions concentrated in vacuo to provide the title compounds.
(R)-Hexane-1,2-diol.      Prepared according to the procedure for CuSO4 N–O bond cleavage
from (R)-2-(N-phenyl-aminooxy)-hexan-1-ol (207 mg, 1 mmol) for 12 h to provide the title
compound as a colorless oil (56.9 mg, 48% yield).  The title compound was identical in all
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respects to the known literature compound.3  [α]D = + 15.7 (c = 1.0, EtOH); reported rotation for
(S)-hexane-1,2-diol [α]D = – 22.1 (c = 1.0, EtOH).3
(R)-3-Phenyl-propane-1,2-diol.     Prepared according to the procedure for CuSO4 N–O bond
cleavage from (R)-3-phenyl-2-(N-phenyl-aminooxy)-propan-1-ol (243.3 mg, 1 mmol) for 12 h to
provide the title compound as a colorless oil (80.2 mg, 68% yield).  The title compound was
identical in all respects to the known literature compound.3 [α]D = + 25.5 (c = 1.0, EtOH);
reported rotation for (S)-3-Phenyl-propane-1,2-diol [α]D = – 29.5 (c = 1.0, EtOH).3
(R)-1-Phenyl-ethane-1,2-diol.     Prepared according to the procedure for CuSO4 N–O bond
cleavage from (R)-2-phenyl-2-(N-phenyl-aminooxy)-ethanol (230 mg, 1 mmol) for 3 h to
provide the title compound as a colorless oil (71.9 mg, 52% yield). The title compound was
identical in all respects to the known literature compound.4  [α]D = + 25.5 (c = 1.0, EtOH);
reported rotation for (S)-1-Phenyl-ethane-1,2-diol [α]D = – 24.7 (c = 1.0, EtOH).
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